DiaMedica Therapeutics Inc (DMAC)
3.17
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
3.18
+0.01
(+0.32%)
After-Hours: 20:00
DiaMedica Therapeutics Cash from Financing (Quarterly): -0.001M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.001M |
| December 31, 2023 | -0.001M |
| September 30, 2023 | -0.006M |
| June 30, 2023 | 36.85M |
| March 31, 2023 | -0.001M |
| December 31, 2022 | -0.001M |
| September 30, 2022 | -0.002M |
| June 30, 2022 | -0.002M |
| March 31, 2022 | -0.001M |
| December 31, 2021 | -0.019M |
| September 30, 2021 | 29.86M |
| June 30, 2021 | -0.001M |
| March 31, 2021 | 0.242M |
| December 31, 2020 | -0.039M |
| September 30, 2020 | 21.19M |
| June 30, 2020 | -0.001M |
| March 31, 2020 | 7.696M |
| December 31, 2019 | -0.001M |
| September 30, 2019 | -0.001M |
| June 30, 2019 | 0.074M |
| March 31, 2019 | -0.002M |
| December 31, 2018 | 14.81M |
| September 30, 2018 | 0.031M |
| June 30, 2018 | 0.049M |
| March 31, 2018 | 6.324M |
| Date | Value |
|---|---|
| December 31, 2017 | 1.549M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 1.983M |
| March 31, 2017 | 0.0067M |
| December 31, 2016 | -0.0191M |
| September 30, 2016 | 3.605M |
| June 30, 2016 | 0.4576M |
| March 31, 2016 | 0.5205M |
| December 31, 2015 | 0.5177M |
| September 30, 2015 | -0.1205M |
| June 30, 2015 | 0.6849M |
| March 31, 2015 | 0.4226M |
| December 31, 2014 | -0.0672M |
| September 30, 2014 | 1.539M |
| June 30, 2014 | 0.0072M |
| March 31, 2014 | 0.1988M |
| December 31, 2013 | 2.007M |
| September 30, 2013 | 0.0998M |
| June 30, 2013 | -0.0864M |
| March 31, 2013 | 3.952M |
| December 31, 2012 | -0.0555M |
| September 30, 2012 | 1.846M |
| June 30, 2012 | 3.324M |
| March 31, 2012 | 0.0501M |
| December 31, 2011 | 0.0545M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.039M
Minimum
Dec 2020
36.85M
Maximum
Jun 2023
4.792M
Average
-0.001M
Median
Sep 2019
Cash from Financing (Quarterly) Benchmarks
| NextCure Inc | 0.001M |
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 4.005M |
| Theriva Biologics Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.653M |
| Cash from Investing (Quarterly) | 4.208M |
| Free Cash Flow | -20.32M |
| Free Cash Flow Per Share (Quarterly) | -0.1755 |
| Free Cash Flow Yield | -18.15% |